Hocoma Spotlights Its Launch of ErigoPro for US Market
Hocoma reports that it has launched the next generation of its rehabilitation robotic device, the ErigoPro, for the US market. According to a news release issued by Hocoma, Craig Hospital in Englewood, Colo, and the Shepherd Center, Atlanta, are the first hospitals in the US implementing the ErigoPro in their daily clinical routine. The new ErigoPro with integrated functional electrical stimulation (FES) is built to further improve mobilization and verticalization of patients with circulatory, neurological, or musculoskeletal conditions through integrated FES.
The release notes that paired with FES, the new ErigoPro also now offers added benefits and therapy options in clinical routine. A combination of mobilization with robotic leg movement and cyclic leg loading allows the ErigoPro to heighten tolerance to an upright or standing position in patients with circulatory, neurological, or musculoskeletal conditions, enabling the stimulation and activation of the central nervous system. In addition to providing a positive impact on the patient’s tolerance to an upright or standing position, ErigoPro therapy aims to activate the central nervous system to reduce spasticity in neurological patients as well.
The release notes that the ErigoPro can also be used to prevent or slow disuse atrophy and maintain or potentially increase the range of motion of leg joints. The product also features a flexible patient harness and a user interface designed to be intuitive and allow full therapy control. The product’s new compact, flexible design aims to ease the device’s transport and support close interaction between the therapist and the patient.
The Erigo FES is engineered to be fully synchronized with the robotic leg movements, and offers up to eight FES channels that can be operated by the therapist on the Erigo’s touchscreen and adjusted to accommodate the patient’s motor abilities.